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We have previously shown invasive vagus nerve stimulation to improve attention and
working memory and alter emotion-attention interaction in patients with refractory
epilepsy, suggesting that VNS might be useful in the treatment of cognitive impairment.
The current research focuses on whether non-invasive, transcutaneous vagus nerve
stimulation (tVNS) has similar effects to VNS. Furthermore, we aimed to assess whether
tVNS has an impact on cognitive control in general or on underlying brain physiology in a
task that mimics everyday life demands where multiple executive functions are engaged
while encountering intervening emotional stimuli. Event-related potentials (ERP) evoked
in such a task, specifically centro-parietal P3 and frontal N2 were used as biomarkers for
attention allocation and cognitive control required to carry out the task. A single-blinded,
sham-controlled, within-subject study on healthy subjects (n = 25) was conducted using
Executive Reaction Time Test (RT-test), a Go/NoGo task engaging multiple executive
functions along with intervening threat-related distractors while EEG was recorded. tVNS
at the left tragus and sham stimulation at the left ear lobe was alternately delivered
throughout the task. To assess the impact of tVNS on neural activity underlying attention
and cognitive control, centro-parietal P3 and frontal N2 peak amplitudes were measured
in Go and NoGo conditions. Task performance was assessed with RTs and different
error types reflecting cognitive control in general and distinct executive functions, such
as working memory and response inhibition. No significant effects due to tVNS on
performance in the Executive RT-test were observed. For N2 there was a main effect
of stimulator status and a significant interaction of trial type (Go, NoGo) and stimulator
status. Post hoc analysis revealed that tVNS resulted in a significant reduction of frontal
N2 only in the NoGo condition. No significant effects were observed for P3 nor were
there any effects of emotion. Diminished NoGo-N2 potential along with unaltered task
performance during tVNS suggests fewer cognitive control resources were required to
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successfully withhold a prepotent response. Though caution is warranted, we suggest
that tVNS may lead to more efficient neural processing with fewer resources needed
for successful cognitive control, providing promise for its potential use in cognitive
enhancement.
Keywords: tVNS, transcutaneous vagus nerve stimulation, neuromodulation, cognition, cognitive control,
executive function, ERP, N2
INTRODUCTION
While cognitive impairment, specifically executive dysfunction,
is a frequent consequence of many brain disorders, such as brain
damage (Riepe et al., 2004), epilepsy (Holmes, 2015), depression
(Rogers et al., 2004), and conditions like burnout (Deligkaris
et al., 2014), adequate therapies are lacking. To find new therapies
for brain disorders and cognitive dysfunction, a growing field of
research is investigating the impact of different neuromodulation
techniques on brain functions. Vagus nerve stimulation (VNS) is
an invasive neuromodulation technique used for the treatment
of pharmacoresistant depression (O’Reardon et al., 2006) and
refractory epilepsy (Englot et al., 2015). We have recently shown
invasive VNS to have beneficial effects on human executive
functions, specifically working memory (Sun et al., 2017b),
suggesting that VNS might be useful in the treatment of
cognitive impairment. Considering the costs and risks involved
in invasive stimulation, it is of great interest to determine whether
a safer non-invasive stimulation, transcutaneous vagus nerve
stimulation (tVNS; Badran et al., 2018b; Redgrave et al., 2018),
has similar potential for enhancing executive functions.
The increased noradrenergic activity has been suggested as
a potential mechanism of cognitive enhancement due to VNS.
Executive functions rely heavily on noradrenergic transmission
and increased noradrenaline (NA) levels have been shown to
improve executive functions in rodents (Roosevelt et al., 2006;
Grimonprez et al., 2015b), and to improve performance in
human clinical populations with deficits in executive functions
(Neuhaus et al., 2007; De Taeye et al., 2014). The neural effects
of tVNS and VNS are thought to be based on the anatomical
connections of the vagus nerve (VN) to brain stem nuclei
releasing neurotransmitters such as NA in many brain regions
via widespread connections (Fanselow, 2012; Butt et al., 2019).
tVNS excites the afferent fibers of the auricular branch of the
VN in the ear while VNS excites the cervical trunk of the VN.
Stimulation is thought to propagate via VN to the brainstem
nuclei, most importantly nucleus tractus solitarius (NTS), dorsal
raphe nuclei (DRN), and locus coeruleus (LC; Van Bockstaele
et al., 1999), which is the major source of NA in the brain (Aston-
Jones and Cohen, 2005). Functional magnetic resonance imaging
(fMRI) studies have shown activation of these brain areas and
many others due to tVNS (Kraus et al., 2007, 2013; Dietrich et al.,
2008; Frangos and Komisaruk, 2017).
However, there is only partial evidence for the tVNS
activating LC-NA system. In human studies, indirect markers of
noradrenergic activation in the brain such as pupil size, salivary
alpha-amylase (sAA) level, and P3 event-related potential
(ERP) amplitude have been used to assess the impact of
neuromodulation, such as tVNS and VNS, on NA release with
only some markers pointing towards increased NA (Colzato
and Beste, 2020). sAA level has been observed to increase due
to tVNS (Ventura-Bort et al., 2018; Warren et al., 2019). In
contrast, no effect on pupil size has been observed in tVNS
studies on healthy subjects (Keute et al., 2019; Warren et al.,
2019; Burger et al., 2020). In VNS studies on patients with
epilepsy and major depression pupil diameter enlargement has
been observed in one study (Jodoin et al., 2015), but not in
another one (Schevernels et al., 2016). P3, on the other hand,
is thought to be modulated by the phasic response of LC-NA
system (Polich, 2007; Nieuwenhuis et al., 2011) and has been
suggested as a potential biomarker for the efficacy of VNS
in patients suffering from epilepsy (De Taeye et al., 2014).
However, the results on P3 amplitude due to tVNS are mixed
(Fischer et al., 2018; Ventura-Bort et al., 2018; Warren et al.,
2019) and impact of tVNS on P3 may only be found in very
specific circumstances (Warren et al., 2020). In addition to the
claimed increase in NA release, VNS and tVNS may increase
GABA release (Capone et al., 2015; Colzato and Beste, 2020)
and long term stimulation may also lead to increased serotonin
levels (Dorr and Debonnel, 2006). Increased GABA release could
support cortical inhibitory control processes (Hermans et al.,
2018) and better signal-to-noise ratio (Leventhal et al., 2003) like
NA (Woodward et al., 1979; Hirata et al., 2006), while serotonin
has been linked to impulse control and cognitive flexibility
(Clarke et al., 2007; Duke et al., 2013).
Even though the underlying mechanism of action of tVNS
remains elusive (see recent review by Colzato and Beste,
2020), multiple studies are showing positive effects of tVNS on
cognitive functions. Wide range of cognitive functions including
associative memory (Jacobs et al., 2015), attentional processing
(Ventura-Bort et al., 2018), response selection (Jongkees et al.,
2018), adaptation to conflict (Fischer et al., 2018), speech
category learning (Llanos et al., 2020) and working memory
dependent inhibitory control processes (Beste et al., 2016) have
been shown to improve due to tVNS. Beste et al. (2016)
suggested that enhancement of inhibitory control, when working
memory was involved in the task, was probably caused by the
improved signal-to-noise ratio, which has been associated with
the functioning of the LC-NA system (Woodward et al., 1979;
Hirata et al., 2006).
Executive functions, such as working memory, response
inhibition, and set-shifting, are higher-order cognitive control
processes that allow for goals rather than impulses or habits
to guide behavior (Miyake et al., 2000; Diamond, 2013). For
example, cognitive control is needed for overriding prepotent
responses, ignoring things irrelevant to the current goals
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(distractors), and for the ability to flexibly shift to novel behaviors
when old habits and impulses are uncalled for. Thus, efficient
cognitive control is crucial for successful daily living and on the
other hand, executive dysfunction is frequently more detrimental
to effective functioning in the society than dysfunction in other
cognitive domains (Back-Madruga et al., 2002; Marshall et al.,
2011). Considering that many brain disorders involving the
prefrontal cortex or its widespread circuits result in executive
dysfunction and that executive functions reflect brain health in
general (Diamond, 2013; Jacobs et al., 2013; Erkkilä et al., 2018),
accurate, sensitive, and ecologically valid assessment methods are
crucial (Lezak, 1982).
Even when interfering with everyday life, executive
dysfunction may not always be depicted in conventional
neuropsychological tests, such as the Stroop test, the Tower of
London test, or theWisconsin Card Sorting Test (Hanna-Pladdy,
2007; Verdejo-García and Pérez-García, 2007; Løvstad et al.,
2012a). Conventional neuropsychological tests are performed in
emotionally neutral and structured environments, as opposed to
unstructured and emotionally burdening everyday life situations
that require a far greater extent of cognitive control (Chaytor and
Schmitter-Edgecombe, 2003; Kuusinen et al., 2018). Consider
the vastly different requirements for cognitive control in a quiet
testing room, where emotionally supportive neuropsychologist
gives clear instructions what to do and one can fully focus on
a single task at hand, in contrast to a busy office with multiple
tasks, unexpected interruptions and occasional emotional events,
such as a frustrated co-worker giving unpleasant feedback.
Emotional distractors, especially when threat-related, tend
to compete for the same attentional and cognitive control
resources as the ongoing task, impairing the task performance
that relies on executive functions and attention allocation
to the task-relevant stimuli (Hartikainen et al., 2000, 2007;
Hartikainen et al., 2010a, 2012). Additional cognitive control
is therefore required in the context of emotional distractors to
maintain attention at the task-relevant stimuli and to control
for the extent of automatic emotion-related responses. Based
on clinical knowledge, the everyday situations where cognitive
control typically fails in individuals with executive dysfunction
tend to involve an emotional component. To that end, when
mimicking everyday requirements for cognitive control, adding
an emotional distractor to the task is called for.
Standardized neuropsychological tests of executive functions
are linked with substantial learning effect in repeated testing,
limiting their reliable use in the assessment of the impact
of an intervention, such as non-invasive neuromodulation, on
executive functions (Bartels et al., 2010). Haatveit et al. (2015)
suggested that even a relatively long testing interval, such as
one year, is not long enough to eliminate learning effects in
tests requiring inhibition and mental flexibility. Also, temporal
accuracy in conventional pen and paper tests is within a range
of seconds limiting sensitivity. In contrast, computer-based
reaction time tests of executive function, such as Executive
Reaction Time-Test (Executive RT-test; Hartikainen et al.,
2010b) used in the current study, allow measurement within the
temporal range of rapid mental events, i.e., milliseconds, and is
relatively robust to learning effect (Erkkilä et al., 2018). Executive
RT-test is an integrated test of working memory, shifting,
response inhibition, and emotional control, that engages frontal
circuits diversely by engaging multiple executive functions
simultaneously in the context of task-irrelevant, threat-related
emotional stimuli (Hartikainen et al., 2010b). Performance speed
in the test has been shown to correlate with the subjective
evaluation of executive functions in daily life (Erkkilä et al., 2018),
suggesting this experimental test succeeds inmimicking everyday
life demands for cognitive control better than conventional
tests, which typically measure one isolated function at the time
(Alvarez and Emory, 2006) and which tend to show poor
correlation with subjective reports of executive dysfunction in
daily life (Løvstad et al., 2012b).
Executive RT-test is sensitive to subtle alterations, both
impairment, and improvement, in executive functions and
emotion-attention interaction due to neuromodulation
(Hartikainen et al., 2014; Sun et al., 2015, 2016, 2017b),
cardiac surgery (Liimatainen et al., 2016), and brain injury
(Mäki-Marttunen et al., 2015, 2017; Kuusinen et al., 2018). The
evidence for Executive RT-test truly assessing executive functions
and the underlying fronto-thalamic circuits have been obtained
with invasive deep brain stimulation (DBS) studies. DBS allows
for temporarily disrupting the functioning of key nodes in these
circuits (Hartikainen et al., 2014; Sun et al., 2015; Peräkylä et al.,
2017). Disruption of specific executive functions linked with
spesific fronto-thalamic circuits (Watanabe and Funahashi,
2012) was found using "lesion on-demand" method with the
Executive RT-test (Peräkylä et al., 2017). Thus, in addition to
reflecting the subjective assessment of one’s executive functions
in daily life, sensitivity to subtle alterations in executive functions
in different clinical populations and robustness in repeated
testing, Executive RT-test is sensitive to changes caused by
neuromodulation in the functioning of fronto-thalamic circuits,
which are important for the executive functions (Hartikainen
et al., 2014; Sun et al., 2015, 2017b; Peräkylä et al., 2017; Sun
et al., 2017a).
In the current study, in addition to investigating the impact
of tVNS on cognitive control in general and on specific executive
functions, such as working memory and response inhibition, we
assessed the impact of tVNS on brain physiology with ERPs. In
contrast to behavioral measures, EEG is a direct and sensitive
measure of brain function. In contrast to functional imaging
studies or conventional neuropsychological assessments, it has a
temporal resolution withinmilliseconds in line with rapidmental
functions. Furthermore, EEG allows information to be obtained
from alterations in brain functions even when no behavioral
response is associated with the task, such as in NoGo condition
when the subject is supposed to withhold from responding. Thus,
the subtle impact of neuromodulation might be depicted only
with ERPs (Sun et al., 2016).
The current study focused on frontal N2 and a subsequent,
centro-parietal P3 ERPs. These ERPs are linked to attention
and cognitive control, with demand for cognitive control
mainly reflected in frontal N2 amplitude (Folstein and Van
Petten, 2008), while attentional resources allocated to processing
motivationally relevant stimuli are reflected in centro-parietal
P3 (Kok, 2001; Polich, 2007). P3 is one of the most studied ERP
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peaks and it is connected to a variety of cognitive processes and
widely distributed brain networks (Downar et al., 2000). Centro-
parietal P3, also referred to as P3b, is known to be modulated
by several factors including task relevance, emotional relevance,
stimulus probability, and LC-NA system activation (Polich,
2007; Nieuwenhuis et al., 2011). P3 amplitude has been reported
to both diminish and increase due to noradrenergic activity
(De Rover et al., 2015). Previous studies using NoGo-task
have suggested that N2 and P3 reflect different phases of
response inhibition or response conflict (Falkenstein et al.,
1999; Donkers and van Boxtel, 2004), but N2 seems to be
a more specific indicator of cognitive control (Kopp et al.,
1996; Kraiser et al., 2006) because frontal N2 amplitude has
been observed to increase when demand for cognitive control
increases (Nieuwenhuis et al., 2003). Donkers and van Boxtel
(2004) suggested that NoGo-N2 could be related to conflict
monitoring rather than response inhibition as its amplitude
increases when the relative frequency of Go responses is
significantly higher than NoGo responses. However, the fact that
N2 may be larger for NoGo condition even when the conditions
are equally frequent, which is the case in the current study,
speaks against mere conflict monitoring behind N2
(Lavric et al., 2004).
Only a few studies are reporting the impact of tVNS on ERPs.
To our knowledge, there is only one previous report of the impact
of tVNS on N2 amplitude (Fischer et al., 2018). Fischer et al.
(2018) observed a greater decrement of N2 amplitude after a
conflict due to tVNS. The authors suggested that the decrement
could be caused by enhancement in the conflict-triggered
adaptation of cognitive control due to tVNS. Furthermore, a
reduction of N2 amplitude due to noninvasive brain stimulation
along with improved cognitive control has been previously
reported in a study by Dubreuil-Vall et al. (2019) using frontal
transcranial direct current stimulation (tDCS). They speculated
based on signal detection theory, that N2 potential reflects
external variables (noise) and internal variables (effort) so that
lower amplitude reflects the better signal to noise ratio, less
effort, and more efficient use of cognitive resources (Dubreuil-
Vall et al., 2019). P3, on the other hand, has been used in previous
tVNS studies as a biomarker of LC-NA system activation with so
far mixed results (Fischer et al., 2018; Ventura-Bort et al., 2018;
Warren et al., 2019, 2020).
The current study aimed to find out whether tVNS has an
impact on cognitive control as reflected in RTs and error rates in
the Executive RT test and/or ERPs; frontal N2 or centro-parietal
P3. Furthermore, we wanted to assess whether tVNS has similar
effects on executive functions, in particular workingmemory and
on affective responses, as observed with invasive VNS in our
previous study (Sun et al., 2017b). We expected the impact of
stimulation on neural processing underlying cognitive control to
be reflected in frontal N2 amplitude. Assuming tVNS, like VNS,
activate the LC-NA system, this would lead to a more efficient
neural processing and consequently either improved cognitive
performance or less cognitive control resources required to
achieve the same performance level. In the latter case diminished
N2 might be expected during tVNS in comparison to sham
stimulation since frontal N2 amplitude is assumed to reflect
the amount of cognitive control resources required to carry
out the task. With NoGo condition requiring more cognitive
control and typically evoking larger N2, we expected to see the
potential effect of tVNS, especially in NoGo-N2. Also, more
efficient cognitive control could result in shorter reaction times
and fewer commission errors during tVNS. With centro-parietal
P3 amplitude intricately linked to attention and the LC-NA
system, we assessed whether tVNS alters the centro-parietal
P3 amplitude. We had no a-priori expectation on the impact of
tVNS on P3 amplitude. Thus, ERP findings are interpreted in
the context of behavioral findings, i.e., whether improvement,
decrement, or no effect on performance is observed.
MATERIALS AND METHODS
Participants
Twenty-five young healthy right-handed subjects, 16 females
and nine males (average age 25.5 ± 4.8 years) recruited from
the local university participated in the study. The average
years of education were 15.3 ± 1.6 years. The sample size
was based on simulation-based power analysis with reaction
times, showing that with 25 subjects and alpha level 0.05,
we have 80% power to detect a difference of 20 ms in
reaction time (RT), which is slightly more than the detected
difference in the previous VNS study (Sun et al., 2017b)
with smaller sample size. The Behavioral Rating Inventory
of Executive Functions–Adult version (BRIEF-A; Roth et al.,
2005) and the Beck’s Depression Inventory (BDI; Beck et al.,
1996) questionnaires were administered to all participants
before testing to rule out underlying depression or executive
dysfunction. Somatic health problems and medications were
reviewed before testing. Exclusion criteria included any history
of psychiatric, neurological, cardiac disorder, or abnormal BDI
or BRIEF-A result. Participants using any medications impacting
the central nervous system (including medication for psychiatric
purposes) were excluded. EEG data of seven subjects were
excluded from ERP analysis, due to technical difficulties and
low signal quality, but their behavioral results were included in
the analysis.
Executive Reaction Time Test (Executive
RT-Test)
EEG was recorded while subjects performed the Executive RT-
Test, a Go/NoGo test tapping into working memory, response
inhibition, emotional interference, and attention (Hartikainen
et al., 2010b). See Figure 1 for the schematic presentation
of the entire experiment and the Executive-RT-test. RTs and
total errors allow assessment of efficiency of cognitive control
in general while analyzing different error types allows the
assessment of distinct executive functions such as working
memory and response inhibition.
Four practice blocks were used to allow for the subject’s
performance to stabilize before the start of the actual experiment
since it has previously been shown that most of the learning in
this task occurs during the first four blocks (Erkkilä et al., 2018).
After the practice there were 4 × 4 experimental blocks with half
of the blocks during tVNS stimulation and a half during sham
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FIGURE 1 | (A) Schematic presentation of the experiment. The experiment
consisted of two transcutaneous vagus nerve stimulation (tVNS) and two
sham stimulation periods. Each period consisted of four blocks of trials with
different response rules (Green-Go and Red-Go). Half of the subjects started
with tVNS and the other half with sham stimulation. Stimulation type was
alternated after every four blocks (10 min) and between different stimulation
types, there was a resting period (4 min). (B) Executive RT-test (Hartikainen
et al., 2010b). Subjects were required to respond to a visual stimulus, a
triangle pointing up or down, by pressing as fast and as accurately as
possible one of the two keys on a response pad according to the orientation
of the previously presented triangle in a Go-condition or withhold from
responding in a NoGo-condition. The orientation of the triangle was
randomized within each block. Whether the subject was required to respond
(Go) to or withhold from responding (NoGo), was indicated by a green or red
traffic light. At the beginning of each block, there are instructions as to
whether red color indicates a Go (Red-Go) and green a NoGo, or vice versa
(Green-Go). The rule for responding changed after each block. A trial begins
with a triangle pointing up or down for 150 ms followed by a fixation cross for
another 150 ms. Subsequently, a traffic light appears for 150 ms. In the
center of the traffic light, there was an emotional stimulus, a black line
drawing resembling a spider, or an emotionally neutral control figure
resembling a flower, both composed of identical line elements in a different
configuration. Total error rate and mean RTs reflect the subject’s cognitive
control in general and each error type a specific cognitive function with
commission errors reflecting response inhibition, missing responses attention,
and incorrect responses working memory, correspondingly.
stimulation, totaling up to 2 × 4 blocks for each stimulation type
and within a stimulation type four blocks with each rule (green-
Go vs. red-Go). One subject performed a total of 1,024 trials,
i.e., 512 Go- and 512 NoGo-trials, 256 Go- and NoGo-trials
during each stimulation type, out of which there were 128 Go
and NoGo trials in the context of each distractor type (emotional
or neutral) and further divided by Go-NoGo-rule there were
64 trials for each trial type. The impact of learning and fatigue
on performance was controlled for with counterbalanced order
of sham stimulation and tVNS between subjects. After every four
blocks, there was a 4-min resting period when the subject was
asked to rest quietly eyes closed and the stimulation type was
changed for the next four blocks.
Performance measures in the Executive RT-test include RT
and three different error types: incorrect responses, missing
responses, and commission errors. In a Go-trial subject canmake
an incorrect response, i.e., press an incorrect button, or miss
responding, reflecting lapses in working memory or attention,
correspondingly. In a NoGo-trial a keypress, i.e., a commission
error, reflects a failure in response inhibition. Different error
types were summed up as total errors indexing cognitive control
in general along with RTs.
Transcutaneous Vagus Nerve Stimulation
tVNS was applied using a CE approved tVNS device (Salustim
Group, Kempele, Finland). The device has two ear-clip
electrodes. The active stimulation electrode was located in the
sensory area of the auricular branch of the vagus nerve in the
left ear, the inner surface of the tragus (tVNS), and the sham
stimulation electrode was placed on the ear lobe of the same ear,
where there are no vagal nerve branches (sham). Before attaching
clips, skin on the tragus and earlobe was cleaned and gel used in
the EEG was applied to decrease the resistance of the skin under
the electrode. The intensity of the stimulation was increased
individually in a staircase manner level by level until the subject
detected slight tingling in the active electrode. The current was
then calibrated to theminimum perceptual level as has been done
in an fMRI study showing activation of cerebral afferents of the
vagal pathway (Badran et al., 2018a). The device has 10 different
intensity levels, with levels 2–4 used in the current study. The
same intensity level was used for active and sham stimulation.
The exact output current for each subject could not be assessed
due to differences in subjects’ skin resistance, but at levels 2–4,
the maximum output current is between 1.6 mA and 3.2 mA
when skin resistance is 5 kΩ. The stimulation mode was constant
with a symmetric, biphasic rectangular waveform, 250 µs pulse
width, and 30 Hz pulse rate, the same frequency as used in the
study of Sun et al. (2017b).
The experiment was conducted as a single-blinded placebo-
controlled within-subject study. The subjects were not aware of
the differences in active vs. sham stimulation locations or any
hypothesis related to the study. Every other subject started with
active stimulation and every other with sham stimulation. Active
and sham stimulation alternated throughout the test so that half
of the subjects performed the first and the third blocks under
tVNS and the second and the fourth under sham stimulation
or the other half the other way around. Recordings were done
between 11 am and 5 pm. Subjects did not report any side effects
during the test or immediately after it.
Electroencephalography (EEG) and Data
Processing
EEG was recorded using 64 Ag/AgCl active electrodes (actiCAP,
Gilching, Germany), QuickAmp amplifier system, and Brain
Vision Recorder software (Brain Products, GmbH) at 500 Hz
sampling rate. The impedance of all electrodes was kept below
5 kΩ throughout the recordings.
Brain Vision Analyzer software (version 2.1, Brain Products
GmbH) was used for the preprocessing of the EEG data and ERP
analyses. EEG was re-referenced to linked right and left mastoids
and signal was band-pass filtered at 0.1–30 Hz. Blinks and other
artifacts were removed using ICA (independent component
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TABLE 1 | Behavioral results of the Executive Reaction time test.










Sham Neutral 327 (57) 2.3 (3.1) 0.8 (1.6) 0.0 (0.0) 0.8 (1.6)
Emotional 327 (65) 2.3 (3.1) 0.8 (2.3) 0.0 (0.0) 0.8 (2.3)
tVNS Neutral 325 (58) 1.6 (2.3) 0.8 (1.6) 0.0 (0.8) 0.8 (1.6)
Emotional 323 (54) 2.3 (3.1) 0.8 (1.6) 0.0 (0.0) 0.8 (1.6)
IQR, Interquartile Range; SD, Standard Deviation.
analysis) based correction. After ICA correction intervals with
over 80 µV peak to peak voltage difference were removed from
the analysis. EEG was epoched into 2,000 ms segments starting
from 200 ms before and 1,800 ms after trial onset.
Remaining single-trial EEG segments were averaged for each
condition (Go or NoGo), stimulator status (active or sham) and
distractor type (emotional or neutral), resulting in eight different
ERP conditions for each subject (In both Go- and NoGo-
conditions: neutral active, neutral sham, emotionally active and
emotional sham). Based on convention (Luck, 2005; Boudewyn
et al., 2018), previous experience on this paradigm and visual
inspection of the individual ERP averages minimum of 50 clean
EEG epochs were required for each ERP condition for the subject
to be included in the analysis. The number of trials in different
conditions was comparable within each subject included in
the analysis. Each trial began with a triangle followed by a
Go/NoGo-signal (traffic light) appearing 300 ms after the trial
onset. N2 component after the Go/NoGo signal was identified
from average waveforms based on the visual inspection and
semiautomatic peak detection based on the timeframes defined
by visual inspection. N2 was defined as the most negative peak
in the timeframe from 200 ms to 350 ms and P3 as a subsequent
positive peak appearing between 300 and 500 ms after the traffic
light i.e., 500–650 ms and 600–800 ms from the trial onset,
correspondingly. Due to the frontal distribution of the N2 peak
(Folstein and Van Petten, 2008), we used frontal channels F1, F2,
F3, and F4 to measure N2 peak amplitudes. For P3 we used CP1,
CP3, CP2, CP4 channels due to centro-parietal distribution of the
P3 reflecting task-related attentional resources and activation of
LC-NA-system (Polich, 2007).
Statistical Analysis
Reaction times and ERP peak amplitudes (N2 and P3)
were analyzed using repeated-measures analysis of variance
(ANOVA). Data were checked for normality and transformed
using Yeo and Johnson (2000) transformation if necessary.
‘‘Stimulator status’’ (active vs. sham) and ‘‘emotional valence’’
(emotional vs. neutral) were used as factors in all analyses. ERP
analysis had an additional factor, ‘‘trial-type’’ (Go vs. NoGo).
Interaction effects were analyzed further with post hoc ANOVAs.
Errors were analyzed with a generalized mixed-effects logistic
regression (Dixon, 2008; Jaeger, 2008). Each error type was
analyzed using a separate model predicting probability to make
that kind of an error. ‘‘Subject’’ was used as random effects
predictor and ‘‘stimulator status’’ and ‘‘emotional valence’’ as
fixed effects predictors. For logistic regression trial outcomes
were dichotomized into binary classes so that for total errors
classes were ‘‘correct’’ (correct button press in Go-trial or no
response in NoGo trial) or ‘‘error’’ (incorrect or missing button
press in Go-trial or any button press in NoGo trial), for incorrect
responses ‘‘incorrect’’ (incorrect button press) or ‘‘other’’ (correct
or missing button press), for missed responses ‘‘miss’’ (missing
button press) or ‘‘other’’ (correct or incorrect button press) and
for commission errors ‘‘commission error’’ (a button was pressed
in NoGo trial) or ‘‘correct’’ (no button press in NoGo trial).
Statistical analysis was done using R statistics v. 3.1.1 (R Core
Team, 2019). Repeated measures ANOVA was done with EZ
package v. 4.2-2 (Lawrence, 2016) and regression analysis with
lme4 package v. 1.1-10 (Bates et al., 2015).
RESULTS
Behavioral Results
Behavioral results can be found in Table 1. Statistical analysis of
the behavioral data did not result in any significant difference,
i.e., tVNS stimulation or emotional stimulus had no statistically
significant effect on reaction times (Table 2) or on any error types
(Table 3). Due to too low number of missing responses, it was not
possible to analyze them.
ERP Results
For N2 peak amplitude there was a main effect of stimulator
status (tVNS, Sham, F(1,17) = 14, 41, p = 0.001, η2G = 0.01 and
a significant interaction of trial type (Go vs. NoGo) and
stimulator status (F(1,17) = 5.06, p = 0.038, η2G = 0.01 Post
hoc analysis revealed that tVNS significantly reduced frontal
N2 peak amplitude compared to sham stimulation only in
NoGo condition: The main effect of repeated measures ANOVA,
F(1,17) = 17.42, p = 0.001, η2G = 0.02, sham = −6.75 ± 4.08 µV,
tVNS =−5.73± 3.50µV (Figure 2). Go-N2 did not result in any
statistically significant results. There were no significant effects of
stimulation on P3 amplitude in either Go or in NoGo condition.
There were no effects of emotion on N2 nor P3 amplitudes.
N2 and P3 amplitudes are presented in Table 4 and the summary
of the statistical analysis in Table 5 and Table 6.
DISCUSSION
The study aimed to investigate whether tVNS has an impact on
human cognitive control in healthy subjects at the behavioral
TABLE 2 | ANOVA table of reaction times.
Predictor dfnum dfden F p η2G
Stimulator status 1 24 0.05 0.825 0.00
Distractor 1 24 1.75 0.199 0.00
Stimulator status × Distractor 1 24 0.45 0.510 0.00
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TABLE 3 | Odds ratios of error analysis.
Predictor Total errors Incorrect responses Commission errors
Intercept 0.01 (0.01–0.02) 0.01 (0.00–0.01) 0.01 (0.01–0.02)
Stimulator ON 0.92 (0.69–1.22) 0.77 (0.49–1.21) 0.90 (0.61–1.33)
Emotional distractor 1.05 (0.80–1.38) 1.07 (0.71–1.63) 0.98 (0.67–1.43)
Stimulator ON × Emotional distractor 1.05 (0.71–1.55) 1.32 (0.72–2.44) 1.00 (0.58–1.72)
Missing responses are omitted from the table because there was none.
FIGURE 2 | Reduced frontal NoGo-N2 during tVNS. Grand averaged event-related potentials (ERPs) in the frontal region (averaged over F1, F2, F3, and F4
electrodes) illustrates significantly diminished NoGo-N2 ERP peak amplitude during tVNS. Furthermore, brain topography maps in the NoGo condition during tVNS
and sham stimulation show reduced frontal negativity in the N2 time window during tVNS in comparison to sham stimulation.
or neural level. Furthermore, we assessed whether tVNS
improves working memory as previously reported with invasive
VNS (Sun et al., 2017b). While no impact of tVNS was
found on behavioral measures of attention, working memory,
response inhibition, emotional interference, or cognitive control
in general, we observed a change in the neural marker of
cognitive control, N2 ERP. The peak amplitude of frontal
NoGo-N2 was significantly reduced during tVNS in contrast to
sham stimulation. Diminished NoGo-N2 amplitude along with
uncompromised response inhibition performance suggests that
during tVNS less cognitive control resources were required to
successfully withhold from responding.
The impact of VNS on enhancing cognitive functions has
been previously linked with increased noradrenaline levels
in animal studies (Roosevelt et al., 2006; Grimonprez et al.,
2015b, see also review Grimonprez et al., 2015a). In human
tVNS studies, surrogate markers of noradrenaline levels have
been assessed. For example, increased alpha-amylase has been
observed following tVNS at the cymba conchae (Ventura-Bort
et al., 2018; Warren et al., 2019). Given the connections between
the vagus nerve and LC (Kalia and Sullivan, 1982; Van Bockstaele
et al., 1999) and the role of the LC-NA system in cognition (Mair
et al., 2005; Hirata et al., 2006; Wang et al., 2007; Manta et al.,
2013), it is possible that similar to VNS, tVNS may increase the
release of noradrenaline. NA is thought to improve the signal-to-
noise ratio (Woodward et al., 1979; Hirata et al., 2006), possibly
resulting in a more efficient neural processing which would
consequently lead to lower resource requirement to complete the
task. Another possible neurotransmitter that could potentially
contribute to the current findings is GABA as it is thought to be
increased by tVNS and believed to contribute to both improved
signal to noise ratio and the inhibitory control (Leventhal et al.,
2003; Capone et al., 2015; Hermans et al., 2018).
Improved neural processing underlying inhibitory control, or
more specifically response inhibition, would lead to a reduced
demand for cognitive control resources in a NoGo-task, which
would be reflected in reduced NoGo-N2 amplitude. In line
with the current results, N2 peak amplitude reduction due to
non-invasive neuromodulation, both tDCS, and tVNS, along
with enhanced cognitive control or cognitive processes closely
linked to it, has been observed in previous studies (Lapenta et al.,
2014; Fischer et al., 2018; Dubreuil-Vall et al., 2019). tDCS to the
left dorsolateral prefrontal cortex was associated with reduced
NoGo-N2 amplitude along with better inhibitory control related
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TABLE 4 | Mean amplitude (µV) and standard deviation of frontal N2 and
centro-parietal P3 peaks during active and sham stimulation.
ERP Stimulation Voltage (µV, sd)
N2 Go Active −5.73 (5.16)
Sham −5.98 (4.83)
N2 NoGo Active −5.73 (3.50)
Sham −6.75 (4.08)
P3 Go Active 5.32 (4.13)
Sham 5.16 (3.69)
P3 NoGo Active 6.25 (3.43)
Sham 6.59 (3.36)
TABLE 5 | ANOVA table of the frontal N2 peak amplitudes.
N2 dfnum dfden F p η2G
Trial type 1 17 0.37 0.550 0.00
Stimulator status 1 17 14.41 0.001 0.01
Distractors 1 17 0.23 0.635 0.00
Trial type × Stimulator status 1 17 5.06 0.038 0.00
Trial type × Distractor 1 17 0.21 0.651 0.00
Stimulator status × Distractor 1 17 0.99 0.334 0.00
Trial type × Stimulator status 1 17 0.08 0.781 0.00
× Distractor
N2 Go
Stimulator status 1 17 1.81 0.196 0.00
N2 NoGo
Stimulator status 1 17 17.42 0.001 0.02
η2G = Generalized Eta Squared; df, degrees of freedom.
TABLE 6 | ANOVA table of the centro-parietal P3 peak amplitudes.
Predictor dfnum dfden F p η2G
Trial type 1 17 2.20 0.157 0.03
Stimulator status 1 17 0.12 0.738 0.00
Distractors 1 17 0.98 0.337 0.00
Trial type × Stimulator status 1 17 2.40 0.140 0.00
Trial type × Distractor 1 17 1.49 0.239 0.00
Stimulator status × Distractor 1 17 1.20 0.288 0.00
Trial type × Stimulator status 1 17 0.31 0.582 0.00
× Distractor
η2G = Generalized Eta Squared; df, degrees of freedom.
to food intake in a study by Lapenta et al. (2014). Similarly, tDCS
to the left dorsolateral prefrontal cortex resulted in N2 reduction
along with improved cognitive control, as seen in speeded RTs
in a Flanker Task in a study by Dubreuil-Vall et al. (2019). In a
tVNS study by Fischer et al. (2018), reduction of N2 amplitude
was linked with enhanced conflict adaptation. tVNS has also
been reported to improve response inhibition when working
memory is required (Sellaro et al., 2015). In the current study
working memory was required to successfully perform the task,
as subjects had to maintain the changing rule of responding and
the direction of the previously presented triangle in working
memory. Combining response inhibition tasks with a working
memory task and intervening emotional distractors competing
for attentional resources emphasizes the role of cognitive control
in intact task performance. Thus, the reduction of NoGo-N2
in the current study may reflect either more efficient cognitive
control in general or more specifically improved inhibitory
control in the context of high demand for cognitive control.
In Go/NoGo tasks N2 amplitude is typically greater for the
infrequent trial type, even if it is the Go-trial (Nieuwenhuis
et al., 2003). In the current study, there was a tendency for
NoGo-N2 to be larger than Go-N2 suggesting more cognitive
control was required in NoGo condition despite equally frequent
Go and NoGo trials. Greater need for cognitive control during
NoGo condition probably relates to the rapid presentation of
the stimuli as well as task instructions emphasizing speed in an
RT test and consequently biasing to Go-responding as suggested
by Nieuwenhuis et al. (2003). While there was a main effect of
stimulation, the interaction between stimulation and trial type
pointed towards the distinct effect of stimulation in NoGo trials
where there was a significant reduction of N2 amplitude due to
stimulation unlike in Go-trials. NoGo-N2 has been suggested
to reflect competition between execution and inhibition of a
response rather than response inhibition per se linking N2 with
cognitive control (Nieuwenhuis et al., 2003). Moreover, ACC,
a frontal brain region involved in cognitive control (Løvstad
et al., 2012b), has been indicated as one of the neural sources
contributing to N2 (Nieuwenhuis et al., 2003). However, other
sources differentiate NoGo-N2 fromGo-N2 even when both trial
types are presented with equal frequency, for example, sources
thought to relate more specifically to response inhibition, such as
sources localized to the right ventral and dorsolateral prefrontal
cortex (Lavric et al., 2004). Thus, N2 potential is not specific to
response inhibition or any other cognitive process but reflects
many different cognitive processes and activity in many different
brain regions with a common denominator in cognitive control
functions concentrated in frontal networks.
Though no impact on behavioral measures of cognitive or
affective functions was observed due to tVNS, we observed a
significant reduction in N2 peak amplitude during a NoGo
condition. While impaired or improved response inhibition
performance can be observed with increased or decreased
commission errors correspondingly, successful response
inhibition is not linked with any visible behavioral response.
ERPs provide information on cognitive brain functions related
to response inhibition and cognitive control even in the absence
of behavioral response. Furthermore, ERPs provide a direct and
more sensitive measure of the impact of neuromodulation on
brain functions than behavior (Sun et al., 2016) providing online
information of brain functions while no behavioral changes can
be observed (Boly et al., 2011; Kouider et al., 2013).
While a higher number of Go-trials than NoGo-trials makes
response inhibition task harder and tends to result in a greater
number of commission errors, there are some benefits to having
an equal number of both trial types. When there is low-frequency
of NoGo trials the brain response evoked by a NoGo trial, such
as ACC activation, may reflect responding to a low-frequency
event rather than response inhibition per se similar to an oddball
paradigm, where the low-frequency event is the target linked
with a response (Braver et al., 2001). In the current study,
there were also other reasons for keeping the frequencies equal.
There were several different trial types, two different response
rules, and two different stimulation types alternating within the
session. An equal number of Go and NoGo trials were justified,
to keep the experiment unbiased and symmetrical and to obtain
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an adequate number of trials for each condition for reliable ERPs
in a time frame that is feasible for the subjects to be engaged
in an attention task. The signal to noise ratio improves as a
function of the square root of the number of trials included in
the average, i.e., the more trials included in the average the better
(Luck, 2005). However, practical aspects such as the length of the
experiment limit the number of trials that can be presented to the
subject. Even though the frequencies of the Go and NoGo trials
were identical in the current study there was still a need to inhibit
responding in a NoGo trial. There was an additional feature to
conventional NoGo-paradigms in the Executive RT test, i.e. the
rule for responding kept changing throughout the experiment. In
the case of a green traffic light indicating a NoGo-rule, the subject
had to overcome an overlearned rule where the green traffic
light is associated with going and red traffic light with stopping.
Furthermore, with the rule for responding changing frequently
throughout the experiment, the subject had to withhold
from responding according to the previous rule. Thus,
even though the 50/50 frequency is not the convention in a
typical NoGo-paradigm we are confident the subjects had to
engage extra cognitive control to withhold from responding
in a NoGo trial with a bias towards responding not due to
infrequency of NoGo condition but due to a fast RT-test
and either overlearned or previous rule biasing
towards responding.
In the previous study by our group (Sun et al., 2017b),
invasive VNS was shown to be effective in improving working
memory performance in patients with refractory epilepsy. In
contrast to that study, in the current study, we did not observe
improvement in performance during tVNS in healthy young
subjects. In the study conducted by Sun et al. (2017b), baseline
cognitive performance of participants was likely compromised
due to their epilepsy and medications used to treat it. Also,
the task was challenging for the subjects in Sun et al. study.
In the current study, the same task was too easy for young,
healthy, highly educated subjects, whose error rates were very
low leaving no room for improvement (ceiling effect). Even if
there was a ceiling effect in errors, in RT there is no ceiling
effect and a change in RT could have shown the improvement
or the decrement in the cognitive control. However, there
was no difference in RT between active and sham stimulation
in any condition. In the future, subjects with suboptimal
cognitive performance and a challenging enough task should be
used to investigate whether tVNS has potential for improving
compromised cognitive performance.
While it was important to investigate whether noninvasive
tVNS has similar effects on cognitive performance as invasive
VNS, it was not surprising that we did not find similar behavioral
results with tVNS in healthy subjects as we did with the
invasive VNS in a clinical population. In addition to obvious
differences in the study groups, it is evident that tVNS applied
to a sensory afferent of the auricular branch of the vagus
nerve transcutaneously is not as effective neuromodulation
method as invasive VNS applied to the cervical trunk of the
vagus nerve. Yet, despite its limitations, the current study is
instrumental in that identical paradigm was used as in the
previous study with invasive VNS, providing invaluable insight
into the effectiveness of tVNS in comparison to invasive VNS in
enhancing cognitive functions.
The stimulation parameters used in this study were chosen
according to the previous VNS study; stimulation frequency of
30 Hz and pulse width of 250 ms were identical in both studies.
Instead of a constant level of current across individuals, we
used individual minimal perceptual threshold when adjusting
stimulation intensity at the beginning of the test similarly to
many previous studies (Badran et al., 2018a; Fischer et al., 2018;
Keute et al., 2019). While stimulation current varied between
subjects, the current was always over 0.5 mA, suggested to
be the minimum level to obtain an effect on sAA with tVNS
(Ventura-Bort et al., 2018; Warren et al., 2019; Colzato and
Beste, 2020). A constant level of current or voltage across
individuals does not guarantee a similar impact in the nerve
or the brain, thus using a sensory perception to systematically
guide titration of the stimulation intensity is justified. Even
stimulation intensities given below the perceptual threshold have
been shown to evoke reliable brainstem potentials, similar to
those evoked by above-threshold stimulation, as well as result
in positive cognitive effects such as faster speech category
learning (Llanos et al., 2020).
In addition to stimulation intensity, individual baseline
neurocognitive state is likely to influence the impact of
neuromodulation. The relationship between cognitive
performance and the level of a neurotransmitter impacting
cognitive control, such as NA, can be illustrated with an inverted
U-curve according to Yerkes-Dodson law (Yerkes and Dodson,
1908; Arnsten, 2000, 2011; Berridge and Spencer, 2016). If the
NA level is at the top of the inverted U-curve at the baseline
before an intervention, such as neuromodulation, no further
improvement in performance can be expected. But if the
level is suboptimal, an increase in the NA level may lead to
an improvement in cognitive performance. Yerkes-Dodson’s
principle may be one of the reasons why improvement in
performance may not be expected if the neurotransmitter level
and cognitive performance are already at the optimal level, as
is likely the case with optimally performing young healthy
subjects. Similar to the impact of neuromodulation on
NA-mediated performance, P3 amplitude depends on the
baseline NA-activity (De Rover et al., 2015). Thus, whether
VNS, tVNS, or any other neuromodulation method modulates
P3 amplitude or cognitive performance will likely depend on
the baseline level of neurotransmitter activity and cognitive
functions of the study group. Thus, not surprisingly, in the
current study, no significant impact of tVNS on P3 amplitude
was obtained.
The study had some limitations. Possibly the differences in the
N2 amplitude were a result of stimulation artifact contaminating
the EEG channels, especially in the reference electrodes located
on the mastoid behind the ear. If that was the case though,
we should have observed the same reduction in all conditions,
and the effect would not have been limited to NoGo-condition
only. Furthermore, since identical electrical stimulation was
administered during active and sham stimulation only to
slightly different locations, any contamination related to the
stimulation artifact would likely have been of similar magnitude
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during active and sham stimulation. Thus, the stimulation
artifact is not likely to explain the differences between the two
conditions. Additionally, we took several measures to minimize
the potential impact of stimulation artifact. All EEG channels
were filtered below 30 Hz and we excluded from the analysis
subjects whose EEG was contaminated by artifacts or who
did not produce clearly distinguishable N2 peaks in the visual
inspection, for any reason. This reduced our ERP sample from
25 to 18 subjects. Taken together, it is plausible to conclude
that the impact of stimulation on cognitive control functions
was a real effect, rather than a confound due to stimulation
artifact. However, future studies are needed to confirm this
finding and link them to behavioral results. Further, it is not
entirely excluded that the decrease in N2 amplitude might be
detrimental to performance if sensitive enough performance
measures were used. Irrespective of whether the observed change
in N2 amplitude reflects beneficial or detrimental effect of tVNS
on response inhibition performance, it provides evidence that
tVNS has an impact on cognitive brain potentials and the
underlying neural circuits opening opportunities for modulating
neural circuits.
It is important to note that unlike previous studies on tVNS
the current study focused exclusively on the immediate and
short-term effects of tVNS on the cognitive control and specific
executive functions along with neural factors underlying them.
The current study does not address the long-term effects of tVNS
on cognition and it may well be that for more prolonged effects
on cognition stimulation period needs to be longer as well. No
previous study has used active and sham tVNS stimulation in
the same session to our knowledge. It is feasible that the lack of
observed behavioral effects of tVNS may have been partly due
to the temporal design of the study. If the 4 min resting period
in between the active and sham stimulation was not enough to
wash out the effects of the stimulation, there may have been
some lingering effects of tVNS during the immediately following
sham stimulation period diluting potential differences between
the active and sham stimulation. However, different wash-out
periods apply for different effects of tVNS fromms range of nerve
cell firing to possibly hours and days related to neuroplasticity.
The fastest observed effects of tVNS occur only 2 ms after
the stimulation pulse in the brainstem, as evidenced with vagal
brainstem evoked potentials (Llanos et al., 2020) which are the
most direct measure of vagal activation due to tVNS in humans.
While we did not measure vagal brainstem evoked potentials, the
counterbalanced sham-controlled within-subject within-session
study design that controls for confounding factors allows for
inferring the later cognitive control-related ERP effect to be due
to vagal activation.
Future studies are needed to explore possible long-term
effects of tVNS on cognition and neurophysiology with longer
stimulation and wash-out periods. Moreover, cymba conchae
have been suggested to be a more efficient location to stimulate
vagus nerve compared to the inner surface of the tragus used in
the current study (Ellrich, 2019). On the other hand, fMRI studies
have shown similar brain effects when stimulating either location
(Kraus et al., 2007; Dietrich et al., 2008; Badran et al., 2018a) and
according to review by Butt et al. (2019), based on the anatomy of
the vagus nerve innervations there is no clear difference between
the two locations. However, to assess the potential for enhancing
cognitive functions with tVNS, future studies are needed to assess
whether the impact of tVNS on brain functions depends on
baseline cognitive performance, on the stimulation location, or
other stimulation parameters.
As for the strengths of the study, according to our knowledge,
this is the first single-blinded, sham-controlled study, where
active and sham stimulation were compared within the same
subject during the same test session. The within-subject study
allows for better control over subject-specific confounding
factors influencing cognitive performance and cognitive ERPs
than comparing two groups. Similarly, within-session study,
where periods of tVNS and sham stimulation alternate allows
for controlling multiple factors that alter cognition day to
day such as sleep, caffeine intake, arousal, fatigue, motivation
level, mood, etc. For example, some tVNS effects on cognition
have been observed only in individuals with low positive
moods (Steenbergen et al., 2020), emphasizing the benefits
of within-subject and within-session approach. The within-
subject study also has higher statistical power allowing a smaller
sample size. Furthermore, the Executive RT Test, while too
easy for our sample, allowed for investigating subtle brain
effects of stimulation on different cognitive control processes,
such as response inhibition, and a comparison to previous
neuromodulation studies, including the invasive VNS study by
Sun et al. (2017b).
CONCLUSION
While tVNS did not show similar results in enhancing cognitive
performance as invasive VNS, reduction of N2 peak amplitude
in NoGo-condition, along with an uncompromised response
inhibition performance was observed. Reduced amplitude of
N2 indicates less cognitive control resources were needed to
maintain the same level of performance in healthy subjects.
This suggests tVNS enhances cognitive control-related neural
processes. In more general terms this study provides novel
ERP evidence for tVNS influencing brain physiology tightly
linked with cognitive operations. While caution is warranted,
the results of this study point to future potential for
noninvasively modulating neural circuits underlying cognitive
control. Given non-invasive neuromodulation techniques have
a huge potential as a safe and feasible treatment option,
future studies are warranted to reproduce these results and
to extend studies to subjects with impaired or compromised
cognitive functions.
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